FASLG and colonic neoplasm: There have been only two separate studies where TRAIL- and FASL-induced apoptosis in primary human colon cancer cells at doses that have been previously shown to be sensitive in several colon cancer cell lines in vitro (Yao et al, 2004; Finnberg et al, 2005).